Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Bioadaptives (BDPT) Total Debt (2016 - 2025)

Bioadaptives' Total Debt history spans 8 years, with the latest figure at $1.7 million for Q4 2025.

  • On a quarterly basis, Total Debt rose 65.09% to $1.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $1.7 million, a 65.09% increase, with the full-year FY2025 number at $1.7 million, up 65.09% from a year prior.
  • Total Debt hit $1.7 million in Q4 2025 for Bioadaptives, up from $967406.0 in the prior quarter.
  • Over the last five years, Total Debt for BDPT hit a ceiling of $1.7 million in Q4 2025 and a floor of $557042.0 in Q4 2021.
  • Historically, Total Debt has averaged $904655.8 across 5 years, with a median of $878024.0 in 2021.
  • The widest YoY moves for Total Debt: up 25905.05% in 2021, down 32.65% in 2021.
  • Tracing BDPT's Total Debt over 5 years: stood at $557042.0 in 2021, then rose by 23.3% to $686856.0 in 2022, then surged by 42.37% to $977872.0 in 2023, then grew by 7.71% to $1.1 million in 2024, then soared by 65.09% to $1.7 million in 2025.
  • Business Quant data shows Total Debt for BDPT at $1.7 million in Q4 2025, $967406.0 in Q3 2025, and $860636.0 in Q2 2025.